Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis

Renal Failure

Volumn 34, Issue 1, 2012, Pages 95-102

  Saglam, Funda ^a   Cavdar, Zahide ^a   Sarioglu, Sulen ^a   Kolatan, Efsun ^a   Oktay, Gulgun ^a   Yilmaz, Osman ^a   Camsari, Taner ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Encapsulating peritoneal sclerosis; Fibrosis; Matrix metalloproteinases; Pioglitazone; Transforming growth factor

Indexed keywords

GELATINASE A; GELATINASE B; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; NONHUMAN; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; RAT; ZYMOGRAPHY;

ANIMALS; FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PERITONEAL FIBROSIS; RATS; RATS, WISTAR; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84055190462     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623498     Document Type: Article

References (26)

1. Plum J, Hermann S, Fussholler A, et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int. 2001;59(Suppl. 78):S42-S47. (Pubitemid 32144068)
2. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int. 1999;55:341-356. (Pubitemid 29004273)
3. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C. Human peritoneal mesothelial cells synthesize IL-1 alpha and beta. Kidney Int. 1994;46:993-1001. (Pubitemid 24319936)
4. Offner FA, Feichtinger H, Stadlmann S, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol. 1996;148:1679-1688. (Pubitemid 26135907)
5. Mandl-Weber S, Cohen CD, Haslinger B, KretzlerM, Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int. 2002;61: 570-578. (Pubitemid 34102598)
6. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev. 1995;5: 571-576.
7. Woessner JF. Matrix metalloproteinases and their inhibitors inconnective tissue remodeling. FASEB J. 1991;5(8):2145-2154.
8. Czoski-Murray C, Warren E, Chilcott J, et al. Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: A systematic review and economic evaluation. Health Technol Assess. 2004;8: 1-91.
9. Ghosh AK, Bhattacharyya S, Lakos G, Mori Y, Chen S-J, Varga J. Peroxisome proliferator-activated receptor-γ signaling and profibrotic responses in normal skin disrupts TGF-β fibroblasts. Arthritis Rheum. 2004;50:1305-1318. (Pubitemid 38480842)
10. Zheng F, Fornoni A, Elliot SJ, et al. Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation. Am J Physiol Renal Physiol. 2002;282:F639-F648. (Pubitemid 34654511)
11. Li M, Pascual G, Glass CK. Peroxisome proliferatoractivated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol. 2000;20: 4699-4707. (Pubitemid 30396117)
12. Shinzato T, Ohya Y, Nakamoto M, Ishida A, Takishita S. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens Res. 2007;30(9): 863-873. (Pubitemid 47578249)
13. Zafiriou S, Stanners SR, Saad S, Polhill TS, Poronnik P, Pollock CA. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. J Am Soc Nephrol. 2005;16(3):638-645. (Pubitemid 41725100)
14. Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun. 2004;315(1):187-195. (Pubitemid 38175204)
15. Dong FQ, Li H, Cai WM, et al. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats. Chin Med J (Engl). 2004;117(7): 1040-1044. (Pubitemid 39144892)
16. Hoff CM. Experimental animal models of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25(Suppl. 4):S57-S66. (Pubitemid 41600360)
17. Sarioglu S, Sis B, Celik A, et al. Quantitative digital histochemistry with methenamine silver staining in renal allograft biopsies excluding pure chronic allograft nephropathy cases. Transplant Proc. 2006;38(2):490-491.
18. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470-479. (Pubitemid 34106290)
19. Heimburger O, Waniewski J, Werynski A, et al. Periton transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int. 1990;38(39):495-506. (Pubitemid 20258753)
20. Io H, Ro Y, Tomino Y, et al. Morphological changes of peritoneum and expression of VEGF in encapsulated sclerosis rat models. Kidney Int. 2004;65:1927-1936. (Pubitemid 38591045)
21. Zhang YF, Yang X, Zhang YJ, et al. Peroxisome proliferatoractivated receptor-gamma is expressed by rat peritoneal mesothelial cells: Its potential role in peritoneal cavity local defense. Am J Nephrol. 2006;26:602-611. (Pubitemid 46143882)
22. Yao Q, Ayala ER, Qian JQ, Stenvinkel P, Axelsson J, Lindholm B. Inhibitive effect of troglitazone on TGF-beta(1) and fibronectin expression in human peritoneal mesothelial cells. Clin Nephrol. 2007;68(5):295-301.
23. Bozkurt D, Ta̧skin H, Sezak M, et al. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model. Adv Perit Dial. 2008;24:32-38.
24. Woessner FJ. MMPs and TIMPs: An historical perspective. Mol Biotechnol. 2002;22(1):33-49.
25. Kim JJ, Li JJ, Kim KS, et al. High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells. Nephrol Dial Transplant. 2008;23:534-541. (Pubitemid 351767608)
26. Margetts PJ, KolbM, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-b1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 2001;12:2029-2039. (Pubitemid 32880339)